These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 943132)

  • 1. Coagulation studies during therapeutic application of arvin.
    Vinazzer H
    Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132
    [No Abstract]   [Full Text] [Related]  

  • 2. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental models of defibrination states.
    Lipiński B
    Pol Med J; 1971; 10(3):619-26. PubMed ID: 4256509
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes--a multicentre trial.
    Latallo ZS
    Thromb Haemost; 1983 Aug; 50(2):604-9. PubMed ID: 6227104
    [No Abstract]   [Full Text] [Related]  

  • 5. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Aug; 42(2):288-93. PubMed ID: 26905070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 8. Interference on the haemostasis in dogs with induced coagulopathies by drugs affecting the platelet function.
    Johnsson H; Olsson P
    Haemostasis; 1976; 5(1):27-37. PubMed ID: 1269996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of experimental postoperative adhesions by ancrod defibrinogenation.
    Buckman RF; Bordos D; Bell WR; Cameron JL
    J Surg Res; 1975 Apr; 18(4):377-84. PubMed ID: 1142753
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of drugs on disseminated intravascular coagulation (DIC). IV. Effects on the thrombin-like enzyme batroxobin on thrombin-induced DIC in rats.
    Markwardt F; Nowak G
    Thromb Res; 1980 Jan 1-15; 17(1-2):103-11. PubMed ID: 6990544
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases].
    Ehrly AM; Köhler HJ
    Vasa; 1976; 5(2):155-62. PubMed ID: 973426
    [No Abstract]   [Full Text] [Related]  

  • 13. Clotting and fibrinolysis.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Thromb Res; 1975 Sep; 7(3):361-72. PubMed ID: 1188838
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of snake venom enzymes on blood coagulation.
    Kornalík F
    Pharmacol Ther; 1985; 29(3):353-405. PubMed ID: 3915360
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T; Ihara H; Takada Y; Fujie M; Takada A
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of stachydrine alkaloid on the blood coagulation system].
    Mansurov MM
    Farmakol Toksikol; 1972; 35(6):715-7. PubMed ID: 4651807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.